Pirro F, Caldarola G, Bernardini N, et al. Risankizumab Versus Secukinumab: A Real-World Efficacy and Cost per Responder Comparison in Patients With Psoriasis in Italy. Dermatol Pract Concept. 2025;15(1):4838. doi:10.5826/dpc.1501a4838